SANOFICONR — Sanofi Consumer Healthcare India Cashflow Statement
0.000.00%
- IN₹113.87bn
- IN₹110.76bn
- IN₹7.25bn
- 86
- 10
- 83
- 66
Annual cashflow statement for Sanofi Consumer Healthcare India, fiscal year end - December 31st, INR millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
---|---|---|
Period Length: | 12 M | 12 M |
Source: | ARS | ARS |
Standards: | IAS | IAS |
Status: | Final | Final |
Net Income/Starting Line | 2,193 | 2,468 |
Depreciation | ||
Non-Cash Items | -40 | -40 |
Unusual Items | ||
Other Non-Cash Items | ||
Changes in Working Capital | -2,175 | 1,917 |
Change in Accounts Receivable | ||
Change in Inventories | ||
Change in Other Assets | ||
Change in Accounts Payable | ||
Change in Other Liabilities | ||
Other Operating Cash Flow | ||
Cash from Operating Activities | -4 | 4,390 |
Capital Expenditures | -40 | -99 |
Purchase of Fixed Assets | ||
Other Investing Cash Flow Items | 40 | 118 |
Other Investing Cash Flow | ||
Cash from Investing Activities | 0 | 19 |
Financing Cash Flow Items | 0 | -4 |
Other Financing Cash Flow | ||
Total Cash Dividends Paid | ||
Net Issuance / Retirement of Stock | ||
Cash from Financing Activities | 20 | -1,156 |
Beginning Cash Balance | ||
Ending Cash Balance | ||
Net Change in Cash | 16 | 3,253 |